Live Breaking News & Updates on Frederik Paulsen Jr|Page 1

Stay updated with breaking news from Frederik paulsen jr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Jack Ma makes a rare appearance on Alibaba's family day at company's Hangzhou campus


news
Jack Ma makes a rare appearance on Alibaba’s family day at company’s Hangzhou campus
Zhou Xin and Masha Borak [email protected], [email protected]
Employees walk through the campus at Alibaba Group Holding’s headquarters during the annual November 11 Singles Day online shopping event in Hangzhou on Monday, Nov. 11, 2019. Photo: Bloomberg
Jack Ma, the founder and former chairman of Alibaba Group Holding, has made a rare public appearance on Monday at the company s Hangzhou campus on AliDay, the annual gathering of the company s family members.
Ma, who retired as Alibaba s chairman on his 55th birthday in September 2019, did not give a speech during the event. An unattributed photograph on NetEase.com s news application showed him clad in a blue T-shirt, surrounded by staff. Alibaba s spokespeople did not immediately respond to requests for comment. ....

Bytedance Tiktok , Vladimir Putin , Bernhard Looney , Jack Ma , Frederik Paulsen Jr , Rural Teacher Initiative , Alibaba Group Holding , China Morning Post Publishers Ltd , Ant Group , South China Morning Post , China Morning Post Alibaba Group Holding , Administration For Market Regulation , Group Holding , Russian Geographical , State Administration , Market Regulation , China Morning Post Publishers , விளாடிமிர் புட்டின் , பலா மா , ஃப்ரெடர்ரிக் பால்சென் ஜூனியர் , கிராமப்புற ஆசிரியர் முயற்சி , அலிபாபா குழு வைத்திருத்தல் , சீனா காலை போஸ்ட் வெளியீட்டாளர்கள் லிமிடெட் , எறும்பு குழு , தெற்கு சீனா காலை போஸ்ட் , குழு வைத்திருத்தல் ,

Billionaire Paulsen's PolyPeptide Group plans Swiss IPO to fund growth


3 Min Read
ZURICH (Reuters) - PolyPeptide Group, controlled by a foundation of Swedish billionaire adventurer Frederik Paulsen Jr., said Monday it plans to list a 40% stake on the Swiss stock exchange to finance the contract drug maker’s growth.
The company, which makes ingredients for U.S.-based Novavax Inc’s, COVID-19 vaccine candidate, plans to list in the second quarter.
It plans to place existing shares and a primary offering, with some proceeds to go for potential acquisitions.
PolyPeptide is eyeing “adjacent” business areas, in not only oligonucleotides that can be used in genetic diseases as well as personalised neoantigen cancer immunotherapies, outgoing Chief Executive Jane Salik said in an interview. ....

Jane Salk , John Miller , Gerry Doyle , Frederik Paulsen Jr , Thomson Reuters Trust Principles , Morgan Stanley , Rothschild Co , Credit Suisse , Philip Morris International , Ferring Group , Danske Bank , U Novavax Inc , Polypeptide Group , Novavax Inc , Raymond De Vre , Bofa Securities , Joint Global Coordinators , Joint Bookrunners , Thomson Reuters Trust , Chemicals Trbc Level 3 , Company News , Equity Capital Changes , Initial Public Offerings , Security Listings Delistings , Biotechnology Amp Medical Research Trbc Level 4 , Biotechnology Amp Medical Research Nec Trbc Level 5 ,